Physician
Lopez-Rosario, Linda
Lopez-Rosario, Linda was paid $2.81M by Medicaid between Jan 2018 and Dec 2024, across 45 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoLOPEZ-ROSARIO, LINDA
MISSION, TX 78572
MISSION, TX 78572
33aNPI1295701878assigned 02/24/2006
33bProvider typePediatrics Physician
28Total paid$2.81M
24GClaims111,601
24DCodes billed45
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#169 of 1,136
Median peer was paid$329K
This provider vs. median8.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 150 | $4K | |
| 2019 | 132 | $4K | |
| 2020 | 4,428 | $95K | |
| 2021 | 24,571 | $585K | |
| 2022 | 28,677 | $768K | |
| 2023 | 28,459 | $719K | |
| 2024incomplete | 25,184 | $637K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 20,037 | 16,527 | $729K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 16% | 18,366 | 15,512 | $447K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.2% | 2,813 | 2,766 | $231K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 7.2% | 499 | 499 | $203K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.6% | 2,129 | 2,100 | $186K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.2% | 2,296 | 2,229 | $173K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.5% | 11,991 | 5,721 | $155K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.1% | 3,441 | 3,303 | $142K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.7% | 10,005 | 5,152 | $103K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.5% | 7,362 | 6,962 | $97K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.2% | 1,285 | 1,227 | $91K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 8,802 | 8,137 | $56K |
33 more codes
| 99429 | 1.7% | 1,475 | $47K | |
| 99000 | 1.2% | 3,541 | $34K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 199 | $17K |
| 92552 | <1% | 626 | $16K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,965 | $16K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 277 | $15K |
| 92081 | <1% | 638 | $15K | |
| 87807 | <1% | 942 | $10K | |
| 90461 | <1% | 2,214 | $10K | |
| 81000 | <1% | 1,845 | $6K | |
| 96160 | <1% | 1,771 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 282 | $3K |
| 97169 | <1% | 110 | $3K | |
| 99381 | <1% | 16 | $920.53 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 40 | $388.11 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 29 | $310.77 |
| 90658 | <1% | 2,051 | $5.80 | |
| 90620 | <1% | 403 | $4.70 | |
| 90651 | <1% | 505 | $4.30 | |
| 90734 | <1% | 505 | $0.20 | |
| 90633 | 0% | 345 | $0.00 | |
| 90670 | 0% | 1,165 | $0.00 | |
| 90655 | 0% | 307 | $0.00 | |
| 90707 | 0% | 29 | $0.00 | |
| 90648 | 0% | 278 | $0.00 | |
| 90681 | 0% | 246 | $0.00 | |
| 90715 | 0% | 25 | $0.00 | |
| 90710 | 0% | 12 | $0.00 | |
| 90697 | 0% | 503 | $0.00 | |
| 90723 | 0% | 146 | $0.00 | |
| 90716 | 0% | 42 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 29 | $0.00 |
| 90696 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.